drugset / Trial / NCT02544802
Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and preliminary efficacy of autologous adipose-derived mesenchymal stem cells (ADMSCs) treatment for patients with primary osteoarthritis knee. Three intra-articular injections of autologous ADMSCs will be performed to subjects at a weekly interval.
Timeline
- Start
- 2015-06
- Primary completion
- 2019-01-31
- Completion
- 2019-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipose-Derived Mesenchymal Stem Cells | Cell therapy | 8e+06 cells | Other |
| Subject | Adipose-Derived Mesenchymal Stem Cells | Cell therapy | 1e+07 cells | Other |